Word

ICHNOS

Status

Registered

Status Code

700

Status Date

Tuesday, July 13, 2021

Serial Number

79290390

Registration Number

6413608

Registration Date

Tuesday, July 13, 2021

Mark Type

4000

Filing Date

Wednesday, May 6, 2020

Published for Opposition

Tuesday, April 27, 2021

Trademark Owner History

Ichnos Sciences SA - Original Registrant

Classifications

41 Educational services, namely, providing workshops and seminars in the fields of cancer treatment, oncology, immunology and pain management; publication of journals featuring research articles and clinical trials for pharmaceutical preparations; education services, namely, conducting online instruction and courses in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; provision of educational content, namely, providing on-line instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; training in the use and operation of medical devices, medical imaging apparatus and medical research apparatus and consultation relating thereto; educational services, namely, conducting live and online seminars, classes, workshops, lectures, panel discussions, and training programs in the field of pharmaceutical products, healthcare and medical diseases, disorders and related treatments; educational services, namely, providing non-downloadable webinars in the field of health and medical information and distribution of course material in connection therewith; education services, namely, developing, arranging and conducting educational programs and providing courses of instruction in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine; providing training programs and developing training programs in the nature of learning methodologies for others relating to the use and operation of medical devices, medical research apparatus and consultation relating thereto; providing online non-downloadable publications, namely, instructional materials in the nature of worksheets and textbooks, featuring study materials in the field of pharmaceutical products, healthcare and medical diseases, disorders and related treatments; conducting educational seminars in the fields of healthcare, the use of pharmaceuticals, and medical devices, medical research, surgery, medical science and medicine

5 Pharmaceutical preparations for human use for the treatment of respiratory disorders; nasal spray preparations; medical and pharmaceutical preparations, namely, inhaler preparations for treatment of Chronic Obstructive Pulmonary Disease (COPD); preparations containing opium alkaloids; pharmaceutical anti-allergic preparations and substances; pharmaceutical antitussive cold preparations; pharmaceutical preparations for the treatment of gout; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances used in the treatment of gastro-intestinal diseases; pharmaceutical preparations for animal skincare; pharmaceutical preparations for inhalation used in the treatment of pulmonary hypertension; pharmaceutical preparations for skin care; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, and for the treatment of inflammatory disorders, and for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in chemotherapy; pharmaceutical and biological preparations for the treatment of cancer; dermatological pharmaceutical preparations; pharmaceutical preparations for use in urology; pharmaceutical preparations for wounds; pharmaceutical preparations, namely, antidepressants; pharmaceutical preparations, namely, appetite suppressants; pharmaceutical preparations, namely, blood clotting aid and delivery systems for use in human and veterinary medicine; pharmaceutical preparations, namely, drug delivery systems comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations, namely, anticoagulants; pharmaceutical products and preparations against dry skin caused by pregnancy; medicated skin care preparations; medicated skin care preparations, namely, gels; pharmaceutical products and preparations for chloasma; pharmaceutical products and preparations for hydrating the skin during pregnancy; pharmaceutical products and preparations for pregnancy blemishes; pharmaceutical products and preparations for preventing skin blemishes during pregnancy; pharmaceutical products and preparations to prevent stretch marks; pharmaceutical products and preparations for preventing swelling in the legs; pharmaceutical products for ophthalmological use; pharmaceutical products for skin care for animals; pharmaceutical products for the treatment of bone diseases; pharmaceutical products for the treatment of joint diseases; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical products for treating respiratory diseases and asthma; pharmaceutical skin lotions; pharmaceutical solutions used in dialysis; pharmaceuticals, namely, anti-infectives; pharmaceuticals, namely, antihelminthics; pharmaceuticals, namely, inducers of erections; pharmaceuticals, namely, lipid lowering agents; analgesic preparations; preparations for the treatment of asthma; preparations for therapeutic or medical purposes, namely, therapeutic medicated skin preparations for treatment of skin diseases; decongestant nasal sprays * ; pharmaceutical products for the treatment of erectile dysfunction; pharmaceuticals for the treatment of erectile dysfunction *

3 Soaps for cosmetic use, namely, cosmetic soaps; skin soaps; shampoos; sunscreens for cosmetic use; perfumery products, namely, perfumery, deodorants for personal use; essential oils; body powders; cosmetic products, namely, cosmetics; antiaging creams; hair lotions; cosmetic skin care preparations; skin creams; skin moisturizing gels; face washing creams, facial cleansers, washing products for facial treatment in the nature of non-medicated soaps; moisturizing body lotions; non-medicinal mouthwashes

35 Campaigns for patient support programs, namely, advertising services promoting public awareness of cancer patients, pain management, skin care, diabetes management, asthma management, chronic obstructive pulmonary disease (COPD) management and of respiratory disease management

45 Licensing of patents; licensing of trademarks; intellectual property licensing in the nature of licensing of intellectual property rights

44 Providing information in the field of medicine and health in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and dietetic advisory services; medical services in the field of oncology, pain management; dermatology, diabetology, respiratory disease and dietetic advisory services; medical assistance in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and dietetic advisory services; hygiene care for human beings in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and dietetic advisory services; medical clinic services; dietetic advisory services; disseminating medical information to patients for better lifestyle management to handle the treatment of side effects in the course of treatment of cancer, pain management, skin care, management of diabetes, management of asthma, Chronic Obstructive Pulmonary Disease (COPD) and respiratory diseases

10 Medical apparatus and instruments, namely, spirometers; medical devices, namely, nasal sprayers in the nature of nasal irrigation vessels, inhalers and nebulizers sold empty; medical devices, namely, autoanalysers; chromatographic medical diagnostic apparatus for testing cancer cells

42 Scientific research for medical purposes in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and biosimilars; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological services, namely, scientific research, analysis, testing in the field of oncology, immunology and pain management; medical research in the fields of oncology, immunology and pain management; clinical research in the fields of oncology, immunology and pain management; scientific research and development; pharmaceutical drug development services; research and development for new products for others; chemical, pharmaceutical, nutraceutical and nutritional analysis and research; dermo-cosmetic and biotechnological analysis and research; design and testing for new product development; diagnostic product testing and analysis, namely, medical research and new product research for industrial use; scientific research in the fields of chemistry, biotechnology and pharmacology; medical and pharmaceutical research services, scientific research services for medical purposes in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and biosimilars, bacteriological research services, biomedical research services, laboratory research services in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and biosimilars, clinical trial services in the nature of conducting clinical trials for others, pharmacological research services, medical research laboratory services in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and biosimilars, and scientific and technological services and research and design relating thereto, namely, scientific research, analysis, testing in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and biosimilars * ; pharmaceutical research and development *

In the statement, " International Classes 5 and 42 " is corrected per the restriction and the fnote dated 3/7/2022

Trademark Events

Dec 7, 2022

Invalidation Reviewed - No Action Required By Office

Nov 15, 2022

Partial Invalidation Of Reg Ext Protection Created

Mar 15, 2022

Correction From Ib Entered - No Review Required

Mar 15, 2022

Case Assigned To Post Registration Paralegal

Mar 15, 2022

Correction Under Section 7 ¿ Processed

Mar 15, 2022

Case Assigned To Post Registration Paralegal

Mar 7, 2022

Limitation From The Ib Examined, No Action Is Needed

Dec 25, 2021

Correction Transaction Received From Ib

Dec 25, 2021

Limitation Of Goods Received From Ib

Nov 29, 2021

Final Decision Transaction Processed By Ib

Nov 10, 2021

Final Disposition Notice Sent To Ib

Nov 10, 2021

Final Disposition Processed

Oct 13, 2021

Final Disposition Notice Created, To Be Sent To Ib

Jul 13, 2021

Registered-Principal Register

Jun 10, 2021

Limitation From The Ib - Request Exam Review

Jun 6, 2021

Limitation Of Goods Received From Ib

Apr 27, 2021

Official Gazette Publication Confirmation E-Mailed

Apr 27, 2021

Published For Opposition

Apr 24, 2021

Notification Processed By Ib

Apr 7, 2021

Notification Of Possible Opposition Sent To Ib

Apr 7, 2021

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

Apr 7, 2021

Notification Of Notice Of Publication E-Mailed

Mar 23, 2021

Approved For Pub - Principal Register

Mar 23, 2021

Examiner's Amendment Entered

Mar 23, 2021

Notification Of Examiners Amendment E-Mailed

Mar 23, 2021

Examiners Amendment E-Mailed

Mar 23, 2021

Examiners Amendment -Written

Mar 23, 2021

Assigned To Examiner

Mar 5, 2021

Teas/Email Correspondence Entered

Mar 5, 2021

Correspondence Received In Law Office

Mar 5, 2021

Teas Response To Office Action Received

Nov 7, 2020

New Representative At Ib Received

Sep 27, 2020

Refusal Processed By Ib

Sep 7, 2020

Non-Final Action Mailed - Refusal Sent To Ib

Sep 3, 2020

Refusal Processed By Mpu

Aug 4, 2020

Non-Final Action (Ib Refusal) Prepared For Review

Aug 4, 2020

Application Filing Receipt Mailed

Aug 3, 2020

Non-Final Action Written

Jul 31, 2020

Assigned To Examiner

Jul 31, 2020

New Application Office Supplied Data Entered In Tram

Jul 30, 2020

Sn Assigned For Sect 66a Appl From Ib